Qiri does not screen a script with one general model. Six specialist checks reason over it in their own domain, and a pharmacist signs the result. Most scripts need only the pharma specialist. The other five are called in when a script needs them.
Most scripts are screened by this specialist alone. It works the whole medication profile: interaction chains, renal and hepatic dose review, allergy and contraindication checks, LASA risk, and therapeutic duplication.
The whole medication list at once, not one drug pair at a time.
Dose read against the patient's renal and hepatic function, surfaced for the pharmacist to review.
The patient's allergy record against every active script, before supply.
Look-alike, sound-alike pairs caught at entry, not at the shelf.
Two medicines doing one job, flagged before the patient takes both.
Some scripts turn on the patient's metabolism rather than the drug list. Those come here: cytochrome P450 pathways, PK/PD behaviour, pharmacogenomic results, and therapeutic drug monitoring.
Inhibitors, inducers and substrates across the P450 enzyme families.
Genetic results read against the RCPA framework as poor, intermediate or ultra-rapid metaboliser phenotypes, with high-risk drug-gene pairs checked against CPIC and DPWG guidelines.
Serum levels, sample timing, and the dose change that follows.
Chemotherapy leaves the least room for error of anything a pharmacy dispenses. This specialist verifies the regimen against protocol, tracks cumulative dose against toxicity ceilings, and flags where a patient sits outside the trial population the guideline was built on.
Regimens against eviQ, the AU protocol library: cycle timing, drug combinations, pre-medications.
Tumour type, stage, body surface area, and organ function.
Lifetime dose against known ceilings, such as anthracycline cardiotoxicity and platinum nephrotoxicity.
Anti-emetic, growth factor and prophylactic cover matched to the cycle.
Australian pharmacy answers to the TGA, the PBS, and a different poisons schedule in every state. This specialist puts them in front of the pharmacist before a supply happens, and the pharmacist makes the call.
Scheduling and registration status, read at the moment of supply.
Special Access Scheme Category A, B and C, and Authorised Prescriber notifications.
Eligibility criteria, restriction codes, and streamlined authority conditions.
S2 through S8, and support for the S8 record-keeping the SUSMP and state Poisons Acts require.
Every dispense is a decision someone could later ask you to justify. This specialist tests each one against duty of care, AHPRA and PSA obligations, and the documentation standard a review would apply.
Each decision against the standard of care a review would apply.
Notes written to the evidentiary standard a professional review would apply.
Pharmacy Board of Australia and AHPRA requirements, and the PSA Code of Ethics.
Where a decision carries elevated risk, and who it should go to next.
A correct dispense the patient does not understand is not a finished job. This specialist sets counselling to the patient's literacy and language, and points to the AU support services they are entitled to.
Instructions and side-effect warnings pitched at the patient's reading level.
Counselling and patient materials in the patient's own language.
Patients drifting off their medicine, early enough to do something about it.
Closing the Gap co-payment, PBS Safety Net, HealthDirect, Lifeline, Beyond Blue, headspace, My Aged Care and NDIS pathways.
Aboriginal and Torres Strait Islander cultural safety to PSA guidelines, plus CALD community considerations.
No extra screen, and no separate compliance step at the end of the month.